Analysis of Construction Progress and Financial Impact of Sanbo Brain Hospital's New Campuses
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
Based on the latest information I have collected, the following is a detailed update on the construction progress of each new campus of Sanbo Brain Hospital:
- Floor Area:63,000 square meters [0][1]
- Planned Beds:480 (the existing Beijing Sanbo old campus has 256 beds) [2]
- Latest Status:Has obtained medical practice license, in the final construction stage [1][2]
- Expected Operation Time:Commence operations in Q1 2026 [2]
- Number of class 100 clean operating rooms increased from 6 to 13 [2]
- Introduced high-end 3.0T MRI [2]
- 96-channel magnetoencephalography (MEG) equipment [2]
- Imported ROSA surgical robot [2]
- Imported electroencephalogram (EEG) detection system [2]
The new campus is positioned as a “large specialist, small general” hospital with neurological specialties as its core. Based on existing disciplines, it will focus on developing emergency medicine, critical care medicine, pain management, rehabilitation medicine, and traditional Chinese medicine departments [2]
- Relocation Time:Officially relocated to the new campus in May 2025 [3][4]
- Planned Beds:200 [2]
- Operation Status:Already in operation, with a significant increase in business volume compared to the old campus [3]
- Added cardiology department [3]
- Purchased medical linear accelerator [3]
- Gamma knife equipment [3]
- Hyperbaric oxygen chamber and other large-scale medical equipment [3]
- Significant improvement in hospital environment [3]
- Opening Time:Officially opened for operation in September 2025 [3][4]
- Planned Beds:200 [2]
- Operation Status:Currently in the ramp-up phase [3]
- Still requires time for market cultivation [3]
- Patient referral efforts are ongoing [3]
- Current patient volume and ward occupancy rate have not yet reached full capacity [3]
| Indicator | Value | Year-on-Year Change |
|---|---|---|
| Total Operating Revenue | RMB 1.273 billion | ~20% year-on-year increase |
| Net Profit Attributable to Parent Shareholders | RMB 83.6282 million | 20.01% year-on-year decrease |
| Q3 Single-Quarter Net Profit | RMB 13.93 million | 63.26% year-on-year decline |
- The company’s interest-bearing liabilities surged to RMB 375 million, representing a year-on-year increase of over 500% [1]
- Before the new campuses generate large-scale revenue, pre-operation investments will continue to impact profit performance [1]
| Campus | Number of Beds |
|---|---|
| Beijing Sanbo Old Campus | 256 |
| Beijing Sanbo Dongba New Campus | 480 |
| Kunming Sanbo | 200 |
| Fujian Sanbo | 300 |
| Chongqing Sanbo Jiangling | 400 |
| Chongqing Sanbo Chang’an | 486 |
| Henan Sanbo | 160 |
| Luoyang Sanbo | 260 |
| Chengdu Dongli | 502 |
| Xi’an Sanbo | 200 |
Total |
2,988 |
Sanbo Brain Hospital is currently in the
[0] Sina Finance - Brain-Computer Interface Concept Surges, Sanbo Brain Hospital’s Stock Price Doubles (https://finance.sina.com.cn/jjxw/2026-01-17/doc-inhhqpcz4801027.shtml)
[1] Guancha.cn - Brain-Computer Interface Concept Surges, Sanbo Brain Hospital’s Stock Price Doubles (https://user.guancha.cn/main/content?id=1585212&s=fwtjgzwz)
[2] Securities Times Network - Sanbo Brain Hospital Interactive Q&A (https://www.stcn.com/quotes/index/sz301293.html)
[3] Securities Times Network - Sanbo Brain Hospital Investor Q&A (https://www.stcn.com/quotes/index/sz301293.html)
[4] Securities Times Network - Operation Status of New Campuses (https://www.stcn.com/quotes/index/sz301293.html)
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
